Norgine BV, a specialist pharmaceutical company in Europe, announced on Tuesday that it named Christopher Bath as its new chief operating officer effective 1 July 2020.
Bath is to report to Peter Stein, chairman and chief executive officer of the company.
Bath has been the company's chief financial officer since 2014. Prior to joining Norgine, he served as head of M&A at Shire plc. He started his career at Rothschild in 2000.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer